India

Daily India: India Generic Drugs: Antitrust Suit Could Cost Billions and more

In this briefing:

  1. India Generic Drugs: Antitrust Suit Could Cost Billions
  2. India: Notes from Hindi Heartland, There Are Issues but People Don’t See a Better Choice than Modi
  3. Farm Loan WaiversTo Dampen Credit Growth Cycle
  4. Are US Stocks A Buy Yet?
  5. Monthly Geopolitical Comment: Redrafting of Global Map of Political Alliances to Continue in 2019

1. India Generic Drugs: Antitrust Suit Could Cost Billions

Table%202%20from%20jepson%20filing

This Insight builds on our previous Insight, India Generic Drugs: US Antitrust Inquiry Widens by discussing estimated potential liabilities and details contained in court filings. Public comments by one of the plaintiffs (47 states) suggest the defendants’ aggregate liability could exceed US$6 billion, the largest previous settlement on record. There is not enough information to apportion potential liability by company, but some companies are better-positioned to bear the cost of a settlement than others. The process could drag on for an undetermined period of time (which helps the defendants). At the same time, the overhang will keep a lid on generic drug prices in the US market. 

Among Indian generic companies, Dr. Reddy’S Laboratories (DRRD IN), Aurobindo Pharma (ARBP IN),Cadila Healthcare (CDH IN), and Glenmark Pharmaceuticals (GNP IN) have the highest risk based on their market caps and exposure to the US market.       

2. India: Notes from Hindi Heartland, There Are Issues but People Don’t See a Better Choice than Modi

We have spent more than ten days in Uttar Pradesh in the second half of December 2018 and tried to assess the chances for BJP and how it could perform in 2019 Lok Sabha elections. Of course the number of seats which each party could win depends more on coalitions, the vote share will remain important nonetheless. We were trying to understand the voting preference of people and the political choices they will be making next year.

First, the good news for BJP is that Prime Minister continues to enjoy almost similar level of popularity as 2014 (the previous Lok Sabha elections) and 2017 (previous Assembly elections in the state). There is also perception that BJP Governments are in general much less corrupt than administration provided by other political parties including Congress. BJP is by far the No. 1 political entity in the state because of Modi’s leadership.

But there is also important bad news, a) the level of satisfaction with state Govt is much lower, b) issues such as cow protection have become nuisance for many people, farmers for example, c) there is a perception that BJP’s simple majority at the Centre and 3/4th majority in state made accountability more difficult and that was the reason governance also suffered in a big way, and, d) people also think that BJP’s elected representatives are not qualitatively different vs. other parties.

3. Farm Loan WaiversTo Dampen Credit Growth Cycle

Capture2

The NPA growth cycle affects credit growth cycle negatively. The recent farm waivers announced by many state governments and the speculations of a nationwide farm loan waiver by the Central government do not augur well for the banks’ credit space in India.

4. Are US Stocks A Buy Yet?

Usra

  • 5%-like rallies on Wall Street are signs of a bear market not a bull market
  • Bull markets require strong liquidity and low risk appetite, neither yet apply
  • Risk appetite readings at minus 12.6 are still above the minus 40 criterion for an upturn
  • Recent large fall in risk appetite consistent with upcoming economic recession

5. Monthly Geopolitical Comment: Redrafting of Global Map of Political Alliances to Continue in 2019

The year 2018 has proven tumultuous for global markets. Rapidly changing geopolitical priorities of the US, an erstwhile hegemon, have played a role no less significant than the withdrawal of liquidity by leading central banks or US monetary policy tightening. The US has openly declared that it is in a state of “cold war” with China. Despite the recent truce, signs are abundant that the confrontation between the two global superpowers will continue into 2019 and beyond. In 2019, we expect more countries to find themselves in a position where they must choose who they want to side with, the US or China. There are other tectonic shifts, too, which are causing re-alignment of global geopolitical alliances.

Found this Interesting?

Learn more about Smartkarma